Cargando…
Positive Impact of Levothyroxine Treatment on Pregnancy Outcome in Euthyroid Women with Thyroid Autoimmunity Affected by Recurrent Miscarriage
Impaired thyroid hormone availability during early pregnancy is associated with recurrent miscarriage (RM) and adverse pregnancy outcomes. The main cause of thyroid dysfunction is thyroid-related autoimmunity (TAI), characterized by a significantly higher serum level of thyroid-stimulating hormone (...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153344/ https://www.ncbi.nlm.nih.gov/pubmed/34068288 http://dx.doi.org/10.3390/jcm10102105 |
_version_ | 1783698780750610432 |
---|---|
author | Dal Lago, Alessandro Galanti, Francesco Miriello, Donatella Marcoccia, Antonella Massimiani, Micol Campagnolo, Luisa Moretti, Costanzo Rago, Rocco |
author_facet | Dal Lago, Alessandro Galanti, Francesco Miriello, Donatella Marcoccia, Antonella Massimiani, Micol Campagnolo, Luisa Moretti, Costanzo Rago, Rocco |
author_sort | Dal Lago, Alessandro |
collection | PubMed |
description | Impaired thyroid hormone availability during early pregnancy is associated with recurrent miscarriage (RM) and adverse pregnancy outcomes. The main cause of thyroid dysfunction is thyroid-related autoimmunity (TAI), characterized by a significantly higher serum level of thyroid-stimulating hormone (TSH) compared to that of women without thyroid autoimmunity. TAI is associated with a significantly increased risk of miscarriage, and the incidence of TAI in women experiencing RM is higher compared to normal fertile women. In the present study, we have performed a retrospective analysis comparing the ability to conceive, the number of miscarriages and full-term pregnancies between 227 euthyroid women with autoimmune thyroid disease affected by RM and treated with levothyroxine (LT4) as adjuvant therapy, and a control group of 230 untreated women. We have observed a significant improvement of full-term pregnancies in treated women (59%) compared to untreated women (13%, p < 0.0001). Compared to the control group, treated women had a lower percentage of miscarriages (12% vs. 30%) and improved capacity to conceive (57% vs. 29%). Using age as a variable, the outcome in women younger than 35 years was not influenced by the LT4 therapy. Whereas, in women over 35 years, supplementation with LT4 significantly reduced the miscarriage rate (p < 0.05). We can conclude that a transient impairment of TH availability, not easily detectable before pregnancy, could be an important cause of RM in a subset of euthyroid women with autoimmune thyroid disease. This transient impairment may be reverted using adjuvant treatment with low doses of LT4. |
format | Online Article Text |
id | pubmed-8153344 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81533442021-05-27 Positive Impact of Levothyroxine Treatment on Pregnancy Outcome in Euthyroid Women with Thyroid Autoimmunity Affected by Recurrent Miscarriage Dal Lago, Alessandro Galanti, Francesco Miriello, Donatella Marcoccia, Antonella Massimiani, Micol Campagnolo, Luisa Moretti, Costanzo Rago, Rocco J Clin Med Article Impaired thyroid hormone availability during early pregnancy is associated with recurrent miscarriage (RM) and adverse pregnancy outcomes. The main cause of thyroid dysfunction is thyroid-related autoimmunity (TAI), characterized by a significantly higher serum level of thyroid-stimulating hormone (TSH) compared to that of women without thyroid autoimmunity. TAI is associated with a significantly increased risk of miscarriage, and the incidence of TAI in women experiencing RM is higher compared to normal fertile women. In the present study, we have performed a retrospective analysis comparing the ability to conceive, the number of miscarriages and full-term pregnancies between 227 euthyroid women with autoimmune thyroid disease affected by RM and treated with levothyroxine (LT4) as adjuvant therapy, and a control group of 230 untreated women. We have observed a significant improvement of full-term pregnancies in treated women (59%) compared to untreated women (13%, p < 0.0001). Compared to the control group, treated women had a lower percentage of miscarriages (12% vs. 30%) and improved capacity to conceive (57% vs. 29%). Using age as a variable, the outcome in women younger than 35 years was not influenced by the LT4 therapy. Whereas, in women over 35 years, supplementation with LT4 significantly reduced the miscarriage rate (p < 0.05). We can conclude that a transient impairment of TH availability, not easily detectable before pregnancy, could be an important cause of RM in a subset of euthyroid women with autoimmune thyroid disease. This transient impairment may be reverted using adjuvant treatment with low doses of LT4. MDPI 2021-05-13 /pmc/articles/PMC8153344/ /pubmed/34068288 http://dx.doi.org/10.3390/jcm10102105 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Dal Lago, Alessandro Galanti, Francesco Miriello, Donatella Marcoccia, Antonella Massimiani, Micol Campagnolo, Luisa Moretti, Costanzo Rago, Rocco Positive Impact of Levothyroxine Treatment on Pregnancy Outcome in Euthyroid Women with Thyroid Autoimmunity Affected by Recurrent Miscarriage |
title | Positive Impact of Levothyroxine Treatment on Pregnancy Outcome in Euthyroid Women with Thyroid Autoimmunity Affected by Recurrent Miscarriage |
title_full | Positive Impact of Levothyroxine Treatment on Pregnancy Outcome in Euthyroid Women with Thyroid Autoimmunity Affected by Recurrent Miscarriage |
title_fullStr | Positive Impact of Levothyroxine Treatment on Pregnancy Outcome in Euthyroid Women with Thyroid Autoimmunity Affected by Recurrent Miscarriage |
title_full_unstemmed | Positive Impact of Levothyroxine Treatment on Pregnancy Outcome in Euthyroid Women with Thyroid Autoimmunity Affected by Recurrent Miscarriage |
title_short | Positive Impact of Levothyroxine Treatment on Pregnancy Outcome in Euthyroid Women with Thyroid Autoimmunity Affected by Recurrent Miscarriage |
title_sort | positive impact of levothyroxine treatment on pregnancy outcome in euthyroid women with thyroid autoimmunity affected by recurrent miscarriage |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153344/ https://www.ncbi.nlm.nih.gov/pubmed/34068288 http://dx.doi.org/10.3390/jcm10102105 |
work_keys_str_mv | AT dallagoalessandro positiveimpactoflevothyroxinetreatmentonpregnancyoutcomeineuthyroidwomenwiththyroidautoimmunityaffectedbyrecurrentmiscarriage AT galantifrancesco positiveimpactoflevothyroxinetreatmentonpregnancyoutcomeineuthyroidwomenwiththyroidautoimmunityaffectedbyrecurrentmiscarriage AT miriellodonatella positiveimpactoflevothyroxinetreatmentonpregnancyoutcomeineuthyroidwomenwiththyroidautoimmunityaffectedbyrecurrentmiscarriage AT marcocciaantonella positiveimpactoflevothyroxinetreatmentonpregnancyoutcomeineuthyroidwomenwiththyroidautoimmunityaffectedbyrecurrentmiscarriage AT massimianimicol positiveimpactoflevothyroxinetreatmentonpregnancyoutcomeineuthyroidwomenwiththyroidautoimmunityaffectedbyrecurrentmiscarriage AT campagnololuisa positiveimpactoflevothyroxinetreatmentonpregnancyoutcomeineuthyroidwomenwiththyroidautoimmunityaffectedbyrecurrentmiscarriage AT moretticostanzo positiveimpactoflevothyroxinetreatmentonpregnancyoutcomeineuthyroidwomenwiththyroidautoimmunityaffectedbyrecurrentmiscarriage AT ragorocco positiveimpactoflevothyroxinetreatmentonpregnancyoutcomeineuthyroidwomenwiththyroidautoimmunityaffectedbyrecurrentmiscarriage |